Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Solid Biosciences Inc. (SLDB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Solid Biosciences Inc. (SLDB), most recent 12 months reported: net loss $207.1M, free cash flow -$187.81M. Latest balance sheet on file: liquid cash $377.68M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): REPLIMUNE GROUP, INC. · Revolution Medicines, Inc. · SAB BIOTHERAPEUTICS, INC. · Sana Biotechnology, Inc. · SILEXION THERAPEUTICS CORP · SCHOLAR ROCK HOLDING CORPORATION · Protara Therapeutics, Inc. · TECTONIC THERAPEUTIC, INC.

Stock screener

Watchlist